lutrate depot 22.5mg powder and solvent for prolonged-release suspension for injection
gp-pharm, s.a - leuprorelin acetate - powder and solvent for prolonged-release suspension for injection - 22.5mg - hormones and related agents. gonadotropin-releasing hormones analogues - it is indicated for palliative treatment of hormone dependent advanced prostate cancer.
lutrate 1 month depot 3.75 mg powder and solvent for prolonged-release suspension for injection
gp-pharm, s.a. - leuprorelin acetate - powder and solvent for prolonged-release suspension for injection - 3.75 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin
lutrate 3 month depot 22.5 mg powder and solvent for prolonged-release suspension for injection
gp-pharm, s.a. - leuprorelin acetate - powder and solvent for prolonged-release suspension for injection - 22.5 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin
lutrate depot monthly 3.75 mg powder and solvent for prolonged-release suspension for injection
mint health ltd 3/4, cantrija complex, triq it-targa, il-maghtab naxxar. nxr6613, malta - leuprorelin acetate - powder and solvent for prolonged-release suspension for injection - leuprorelin acetate 3.75 mg - endocrine therapy
leuprorelin 3-month depot 22.5mg powder and solvent for prolonged-release suspension for injection
gp-pharm, s.a. - leuprorelin acetate - pdr+solv for pr for susp for inj - 22.5 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin - endocrine therapy. hormones and related agents. gonadotropin-releasing hormones - it is indicated for palliative treatment of hormone dependent advanced prostate cancer.
leuprorelin 1-month depot 3.75 mg powder and solvent for prolonged-release suspension for injection
gp-pharm, s.a. - leuprorelin acetate - pdr+solv for pr for susp for inj - 3.75 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin
lutrate 1 month depot 3.75 mg powder and solvent for prolonged-release suspension for injection
mercury pharmaceuticals ltd - leuprorelin acetate - powder and solvent for suspension for injection - 3.75 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin - endocrine therapy. hormones and related agents. gonadotropin-releasing hormones analogues - it is indicated for palliative treatment of locally advanced or metastatic prostate cancer
lutrate 3 month depot 22.5 mg powder and solvent for prolonged-release suspension for injection
mercury pharmaceuticals ltd - leuprorelin acetate - powder and solvent for suspension for injection - 22.5 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin - endocrine therapy. hormones and related agents. gonadotropin-releasing hormones analogues - it t is indicated for palliative treatment of hormone dependent advanced prostate cancer
lutrate 1 month depot 3.75 mg powder and solvent for prolonged-release suspension for injection
mercury pharmaceuticals limited - leuprorelin acetate - powder and solvent for prolonged-release suspension for injection - 3.75 mg - endocrine therapy. hormones and related agents. gonadotropin-releasing hormones analogues - lutrate 1 month depot is indicated for palliative treatment of locally advanced or metastatic prostate cancer.
lutrate 3 month depot 22.5 mg powder and solvent for prolonged-release suspension for injection
mercury pharmaceuticals limited - leuprorelin acetate - powder and solvent for prolonged-release suspension for injection. - 22.5 mg - endocrine therapy. hormones and related agents. gonadotropin-releasing hormones analogues - lutrate 3 month depot is indicated for palliative treatment of hormone dependent advanced prostate cancer.